Top compounds associated with response to INTS4


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA DBeQ CTRPv2 pan-cancer AAC 0.038 0.3
mRNA SCH-79797 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.049 0.3
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.037 0.3
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA austocystin d CTRPv2 pan-cancer AAC 0.038 0.3
mRNA GSK-J4 CTRPv2 pan-cancer AAC 0.11 0.3
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.032 0.3
Download CSV